Paragon Private Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$426K Buy
3,543
+302
+9% +$34.9K 0.13% 154
2025
Q4
$341K Buy
3,241
+170
+6% +$16K 0.1% 167
2025
Q3
$258K Buy
+3,071
New +$253K 0.08% 196

Other funds holding MRK

Paragon Private Wealth Management's MRK Position: Q1 2026 in Review

Paragon Private Wealth Management increased its Merck (MRK) stake by 9.3% in Q1 2026, buying an estimated $34.9K and bringing the position to 3,543 shares worth $426K. The position accounts for 0.13% of the portfolio, ranked #154.

Paragon Private Wealth Management first reported a position in MRK in Q3 2025 and has held it in 3 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Paragon Private Wealth Management held 3,543 shares of Merck worth $426K as of Q1 2026.
  • Paragon Private Wealth Management bought 302 Merck shares in Q1 2026, an estimated $34.9K.
  • Merck made up 0.13% of Paragon Private Wealth Management's portfolio in Q1 2026, its #154 holding.
  • Paragon Private Wealth Management first reported a position in Merck in Q3 2025 and has held it in 3 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Paragon Private Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.